Diplopia Is Frequent and Associated with Motor and Non-Motor Severity in Parkinson's Disease: Results from the COPPADIS Cohort at 2-Year Follow-Up.

No Thumbnail Available

Date

2021-12-17

Authors

Santos Garcia, Diego
Naya-Rios, Lucia
de-Deus-Fonticoba, Teresa
Cores-Bartolome, Carlos
Garcia-Roca, Lucia
Feal-Painceiras, Maria
Martinez-Miro, Cristina
Canfield, Hector
Jesus, Silvia
Aguilar, Miquel

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

MDPI AG
Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

Diplopia is relatively common in Parkinson's disease (PD) but is still understudied. Our aim was to analyze the frequency of diplopia in PD patients from a multicenter Spanish cohort, to compare the frequency with a control group, and to identify factors associated with it. PD patients who were recruited from January 2016 to November 2017 (baseline visit; V0) and evaluated again at a 2-year ± 30 days follow-up (V2) from 35 centers of Spain from the COPPADIS cohort were included in this longitudinal prospective study. The patients and controls were classified as "with diplopia" or "without diplopia" according to item 15 of the Non-Motor Symptoms Scale (NMSS) at V0, V1 (1-year ± 15 days), and V2 for the patients and at V0 and V2 for the controls. The frequency of diplopia in the PD patients was 13.6% (94/691) at V0 (1.9% in controls [4/206]; p Diplopia represents a frequent symptom in PD patients and is associated with motor and non-motor severity.

Description

MeSH Terms

Humans
Prospective Studies
Parkinson Disease
Follow-Up Studies
Diplopia
Spain
Control Groups

DeCS Terms

Diplopía
Pacientes
España
Grupos control
Estudios prospectivos
Enfermedad de Parkinson
Organización Mundial de la Salud

CIE Terms

Keywords

PIGD, Parkinson’s disease, Tremor, changes, motor, phenotype

Citation

Santos García D, Naya Ríos L, de Deus Fonticoba T, Cores Bartolomé C, García Roca L, Feal Painceiras M, et al. Diplopia Is Frequent and Associated with Motor and Non-Motor Severity in Parkinson's Disease: Results from the COPPADIS Cohort at 2-Year Follow-Up. Diagnostics (Basel). 2021 Dec 17;11(12):2380.